To continuously promote the integration and interaction between basic research and clinical medicine in the field of metabolism and diseases, enhance researchers 'and healthcare professionals' awareness of cutting-edge developments, provide an interdisciplinary exchange platform, and strengthen multidisciplinary collaboration, the "2025 Huaxi Metabolism and Disease Academic Annual Conference" was successfully held in Chengdu, Sichuan from July 19 to 20,2025! This conference was jointly organized by the Chengdu High-Tech Medical Association, the Diabetes and Metabolism Research Center of West China Hospital of Sichuan University, and the Endocrinology and Metabolism Department of West China Hospital of Sichuan University. It brought together medical professionals specializing in endocrinology and related fields from comprehensive hospitals and other medical institutions across the region, facilitating discussions on the latest trends and advancements in metabolism and disease research. Over 300 participants attended the event.
01
opening ceremony
Tong Nanwei, Director
Western Endocrinology and Metabolism Branch of Chengdu High-tech Medical Association
West China Hospital, Sichuan University
At the opening ceremony on July 19, Professor Tong Nanwei first extended a warm welcome and sincere gratitude to all attendees. He emphasized that metabolic diseases, as a hot-button issue and major challenge in modern medicine, directly impact patients' health outcomes. This academic conference provides a rare platform for healthcare professionals across the region to exchange insights, discuss cutting-edge research, and share clinical experiences. By collaborating to advance the diagnosis and treatment of endocrine and metabolic disorders, we aim to strengthen inter-institutional cooperation, foster multidisciplinary collaboration, and collectively contribute wisdom and expertise to elevate medical standards in this field.
Vice President, Chen Mao
West China Hospital, Sichuan University
Vice President Chen Mao emphasized that metabolism and disease research constitute a highly challenging yet innovative frontier in medical science. The interdisciplinary nature of this field necessitates close collaboration among multiple stakeholders. The timely convening of this annual conference has established an exceptional platform for participants to exchange knowledge and spark intellectual inspiration. He encouraged attendees to actively engage in discussions and apply the latest concepts and technologies to their professional practice, thereby improving patient care. With heartfelt dedication, Vice President Chen's inspiring remarks energized all medical professionals present, fostering a vibrant academic atmosphere and fostering positive professional exchanges at this scholarly gathering.
02
learned report
Zhang Yuwei West China Hospital, Sichuan University
Study on the role and mechanism of microRNA in thyroid eye disease
Zhang Huimei Southern Hospital, Southern Medical University
New Mechanisms and Clinical Interventions of NASH
Zhang Min Sichuan Provincial People's Hospital
Application of New Insulin in Diabetes Management from the 2024 CDS Guidelines
Deng Cheng West China Hospital, Sichuan University
Darwin Medicine of Bird Lipid Metabolism
Wei Dong Chengdu Second People's Hospital
"Four Highs Co-managed, Protecting the Heart and Kidney: GLP-1 Family adds a new product: Yesupaglutide α"
Li Shuye West China Hospital, Sichuan University
Expert Consensus on Diagnosis and Treatment of Hypothalamic Obesity Related to Lesions in the Saddle Area in China
Zhang Yuwei West China Hospital, Sichuan University
"Opening a New Era of TED Therapy —— Phase 3 Clinical Data of Tiotouyusimab N01"
Fu Xianghui West China Hospital, Sichuan University
Regulation of Glucose and Lipid Metabolism by RNA G-Quartet
Nanwei Tong West China Hospital, Sichuan University
New Ideas, New Choices: Clinical Application and Research Status of SGLT-i
Qingguo Lü West China Hospital, Sichuan University
Gut flora: A new therapeutic target for hyperuricemia/gout
Hu Cheng Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Regulation of Metabolic Steady State in Adipose Tissue
Yang Jichun, School of Basic Medicine, Peking University
BHMT1 and Metabolic Cardiovascular Disease
Fang Zhang, West China Hospital of Sichuan University
The Key to Breakthrough, The Fruit of Achievement: A Study and Interpretation of PIONEER Series
Li Xiaomu, Zhongshan Hospital, Fudan University
"Basic and Clinical Research on the Regulation of βCell Function"
Chang Yongsheng Tianjin Medical University
SIRT6 and Energy Metabolism
Nanwei Tong West China Hospital, Sichuan University
On the Safety of Antithyroid Drugs
Zhou Guangju Affiliated Hospital of Chuanbei Medical College
"Cardiovascular and Kidney Protection, Confidence of Choice: Optimization of Early Management Strategies for T2DM-related CKD Patients from the CONFIDENCE Study"
Chen Haiyang West China Hospital, Sichuan University
《Lipoic acid functions in Paneth cells to prevent human intestinal stem cell aging》
Wang Tan, Dahuaxi Hospital, Sichuan
Selection of anti-soporosis drugs with high fracture risk
03
closing ceremony
Tong Nanwei, Director
Western Endocrinology and Metabolism Branch of Chengdu High-tech Medical Association
West China Hospital, Sichuan University
At the closing ceremony, Professor Tong Nanwei highly praised the successful hosting of the conference. He emphasized that the event had established an excellent platform for the field of metabolism and diseases, enabling participants to gain clearer insights into its developmental trends and effectively promote the integration of basic research with clinical practice. He also expressed hope that medical professionals would continue to follow advancements in metabolic and disease research, strengthen collaboration and exchanges, and make greater contributions to improving healthcare standards and serving patients.
This conference has significantly advanced academic exchanges and scientific innovation, showcasing cutting-edge research achievements in the field while deepening the integration of basic research and clinical medicine in metabolic and disease studies. Moving forward, the Chengdu High-Tech Medical Association will continue to uphold its mission of "strengthening grassroots foundations and promoting translational applications." We are committed to building an academic exchange platform that is rooted in high-tech innovation, serves Sichuan-Chongqing regions, extends nationwide, and embraces global perspectives. By providing comprehensive support and services to experts, we aim to propel the medical field to new heights of development.
